Cheruvu Pavan
Insider CIK 1731741 · AXON Principal Executive Officer, Director · RTSN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RTSN Retension Pharmaceuticals, | A Award deriv | 2026-10-13 | 2026-10-13 | 5,636 | — | $0 | 5,636 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | D To issuer deriv | 2021-12-08 | 2021-12-09 | 37,567 | — | $0 | 75,133 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | F Tax w/h | 2021-12-08 | 2021-12-09 | 14,884 | $1.42 | $21.1K | 203,109 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award | 2021-12-08 | 2021-12-09 | 37,567 | — | $0 | 217,993 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 682,100 | — | $0 | 682,100 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | P Buy | 2021-03-23 | 2021-03-24 | 100,000 | $2.48 | $248.0K | 180,426 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | D To issuer deriv | 2021-03-17 | 2021-03-19 | 22,590 | — | $0 | 0 | SEC↗ |
| SIOX Sio Gene Therapies Inc. | A Award | 2021-03-17 | 2021-03-19 | 22,590 | — | $0 | 80,426 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | P Buy | 2020-07-08 | 2020-07-10 | 37,500 | $2.74 | $102.8K | 57,836 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | D To issuer deriv | 2020-06-11 | 2020-06-15 | 22,591 | — | $0 | 22,590 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | F Tax w/h | 2020-06-11 | 2020-06-15 | 9,755 | $3.09 | $30.1K | 20,336 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award | 2020-06-11 | 2020-06-15 | 22,591 | — | $0 | 30,091 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 112,700 | — | $0 | 112,700 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2020-04-15 | 2020-04-17 | 169,100 | — | $0 | 169,100 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | A Award deriv | 2019-09-21 | 2019-09-24 | 45,181 | — | $0 | 45,181 | SEC↗ |
| AXGT Axovant Gene Therapies Ltd | P Buy | 2019-06-14 | 2019-06-17 | 7,500 | $5.21 | $39.1K | 7,500 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 1,596,000 | — | $0 | 1,596,000 | SEC↗ |
| AXGT Axovant Sciences Ltd. | A Award deriv | 2019-04-15 | 2019-04-17 | 1,596,000 | — | $0 | 1,596,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2018-02-13 | 2018-02-15 | 1,940,185 | — | $0 | 1,940,185 | SEC↗ |